Physician profile

Ankur Garg

Neurology (Psychiatry & Neurology) · Winter Park, FL

NPI 1598961807

$18,507.35

in general payments reported to CMS, 2019-2025

33 companies · $2,134 in 2025

The $2,134 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$7,200.00
Food and Beverage$5,812.02
Travel and Lodging$57.51

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Penumbra, INC. $9,873.81 2021-2025 Penumbra System, Benchmark, Red 72
Medtronic, INC. $2,465.96 2021-2025 Pipeline, Intellis Adaptivestim, Axium Primetm
Medtronic USA, INC. $1,220.32 2019-2020
Microvention, INC. $931.55 2020-2025 Web Aneurysm Embolization System, Stent, Hydrosoft Advanced
Boston Scientific Corporation $538.21 2019-2025 Lux-Dx Insertable Cardiac Monitor, General - Pain Management, Wavewriter Alpha Prime 16
Stryker Corporation $517.77 2019-2025 Duramatrix, Target, Axs Vecta 71
Carlsmed, INC. $379.63 2023-2025 Aprevo
Depuy Synthes Sales INC. $362.54 2019-2025 Embotrap, Cerebase, Trufill
Balt USA, LLC $241.36 2023
Rapid Medical LTD $230.39 2025 Comaneci 17, Tigertriever 17 Revascularization Device
Microtransponder, INC. $216.38 2024
Imperative Care, INC $177.99 2020-2024 Zoom 88-T Large Distal Platform
W. L. Gore & Associates, INC. $160.55 2019-2023 Gore Propaten Vascular Graft
Route 92 Medical, INC. $153.45 2024 8f Base Camp Sheath System
Averitas Pharma INC. $123.35 2023 Qutenza
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Viz.Ai, INC. $119.14 2022
Genentech USA, INC. $114.38 2019
Astrazeneca Pharmaceuticals LP $113.85 2024 Andexxa
Abbott Laboratories $112.52 2022-2025 Amplatzer Talisman, Infinity, Eterna
Qapel Medical INC $87.18 2023
Corindus INC. $80.47 2019
Medtronic Vascular, INC. $56.59 2020
Aesculap, INC. $34.50 2024 Aesculap
Sunovion Pharmaceuticals INC. $26.52 2019-2020
Centinel Spine, LLC $26.04 2024 Prodisc L
Novocure INC. $24.21 2024 Optune
Nevro Corp. $20.14 2021
Monteris Medical Corporation $19.93 2023 Neuroblate
Inspiremd LTD $19.16 2025 Cguard Prime Carotid Stent System
Biotronik Nro, INC. $17.66 2025 Prospera
Curonix LLC $16.33 2023 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Arteriocyte Medical Systems, INC. $14.64 2023 Magellan
Ceribell, INC. $10.83 2023 Ceribell Rapid Response Eeg

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ankur Garg

$18,507.35

in general payments reported 2019-2025

Years
2019-2025
Top company
Penumbra, INC.
Context
The $2,134 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).

https://glasscript.com/doctor/208658/ankur-garg

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.